Discover in video the commitment of Servier in oncology
Cancer causes more than one in four of all deaths, making it the second leading cause of death in the world, and numbers are on the rise.
To respond to the growing need for therapeutic solutions, Servier has made oncology one of its foremost priorities, investing 50% of its R&D budget in the field as of 2020-2021.
As a company committed to improving patient health, the Group aims to become renowned for developing innovative cancer treatments by initiating therapeutic progress where the needs are greatest.
On the occasion of Blue March, the colorectal cancer awareness month, discover Servier’s commitment to oncology through a video clip.